Trupanion (NASDAQ:TRUP) Trading Down 5.5% – Time to Sell?

Shares of Trupanion, Inc. (NASDAQ:TRUP) fell 5.5% during trading on Monday . The stock traded as low as $51.58 and last traded at $51.58. 271,596 shares changed hands during mid-day trading, a decline of 60% from the average session volume of 679,104 shares. The stock had previously closed at $54.56.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on TRUP. Northland Securities raised their price objective on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a report on Thursday. Bank of America lifted their price target on Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a report on Friday, September 20th. William Blair started coverage on shares of Trupanion in a report on Friday, July 19th. They set an “outperform” rating on the stock. Evercore ISI upgraded shares of Trupanion to a “strong-buy” rating in a report on Friday, August 9th. Finally, Stifel Nicolaus increased their price target on shares of Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research note on Monday, September 23rd. Four analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Trupanion presently has a consensus rating of “Moderate Buy” and an average price target of $44.67.

Trupanion Price Performance

The business’s 50 day moving average price is $47.08 and its 200-day moving average price is $36.43. The company has a quick ratio of 1.63, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. The company has a market cap of $2.11 billion, a PE ratio of -157.22 and a beta of 1.69.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The company had revenue of $327.50 million during the quarter, compared to analysts’ expectations of $321.79 million. During the same period in the prior year, the company posted ($0.10) EPS. The firm’s revenue for the quarter was up 14.6% on a year-over-year basis. As a group, analysts forecast that Trupanion, Inc. will post -0.34 earnings per share for the current year.

Insider Buying and Selling

In other Trupanion news, CFO Fawwad Qureshi sold 624 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $46.54, for a total transaction of $29,040.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CFO Fawwad Qureshi sold 624 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $46.54, for a total transaction of $29,040.96. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Margaret Tooth sold 7,500 shares of the business’s stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the sale, the chief executive officer now directly owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 8,764 shares of company stock worth $405,238. Insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Trupanion

A number of hedge funds have recently added to or reduced their stakes in the business. GAMMA Investing LLC lifted its position in shares of Trupanion by 70.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after buying an additional 596 shares during the last quarter. Headlands Technologies LLC acquired a new position in Trupanion in the second quarter valued at approximately $162,000. Oppenheimer Asset Management Inc. bought a new position in shares of Trupanion during the second quarter valued at approximately $235,000. Handelsbanken Fonder AB bought a new position in Trupanion during the 3rd quarter worth $248,000. Finally, Bayesian Capital Management LP acquired a new position in shares of Trupanion during the first quarter valued at $253,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.